Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayesha A Shafi

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Cancer Research|July 14, 2019
Cancer and the Circadian ClockAyesha A Shafi, Karen E Knudsen
Cancer Medicine|May 30, 2025
Understanding Racial Disparities in Prostate Cancer: A Multifaceted ApproachCharles Cobbs, Gregory T Chesnut, Ayesha A Shafi
Urology|January 24, 2023
Time Matters: Importance of Circadian Rhythms, Disruption, and Chronotherapy in Urologic MalignanciesSierra T Pence, Gregory T Chesnut, Ayesha A Shafi
Steroids|February 6, 2013
Androgen receptor splice variants are resistant to inhibitors of Hsp90 and FKBP52, which alter androgen receptor activity and expressionAyesha A Shafi, Marc B Cox, Nancy L Weigel
Pharmacology & Therapeutics|July 18, 2013
Androgen receptors in hormone-dependent and castration-resistant prostate cancerAyesha A Shafi, Aihua E Yen, Nancy L Weigel
The International Journal of Biochemistry & Cell Biology|July 11, 2014
Androgen receptor and its splice variant, AR-V7, differentially regulate FOXA1 sensitive genes in LNCaP prostate cancer cellsWilliam C Krause, Ayesha A Shafi, Manjula Nakka, et al.
Scientific Reports|March 31, 2022
Cistrome and transcriptome analysis identifies unique androgen receptor (AR) and AR-V7 splice variant chromatin binding and transcriptional activitiesPaul Basil, Matthew J Robertson, William E Bingman, et al.
International Journal of Oncology|November 16, 2012
Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expressionSuqin He, Chaohua Zhang, Ayesha A Shafi, et al.
Oncotarget|September 18, 2015
Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cellsAyesha A Shafi, Vasanta Putluri, James M Arnold, et al.
Oncogene|November 13, 2021
Mutant p53 elicits context-dependent pro-tumorigenic phenotypesJennifer J McCann, Irina A Vasilevskaya, Christopher McNair, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cancer Research|July 14, 2019
Cancer and the Circadian ClockAyesha A Shafi, Karen E Knudsen
Cancer Medicine|May 30, 2025
Understanding Racial Disparities in Prostate Cancer: A Multifaceted ApproachCharles Cobbs, Gregory T Chesnut, Ayesha A Shafi
Urology|January 24, 2023
Time Matters: Importance of Circadian Rhythms, Disruption, and Chronotherapy in Urologic MalignanciesSierra T Pence, Gregory T Chesnut, Ayesha A Shafi
Steroids|February 6, 2013
Androgen receptor splice variants are resistant to inhibitors of Hsp90 and FKBP52, which alter androgen receptor activity and expressionAyesha A Shafi, Marc B Cox, Nancy L Weigel
Pharmacology & Therapeutics|July 18, 2013
Androgen receptors in hormone-dependent and castration-resistant prostate cancerAyesha A Shafi, Aihua E Yen, Nancy L Weigel
The International Journal of Biochemistry & Cell Biology|July 11, 2014
Androgen receptor and its splice variant, AR-V7, differentially regulate FOXA1 sensitive genes in LNCaP prostate cancer cellsWilliam C Krause, Ayesha A Shafi, Manjula Nakka, et al.
Scientific Reports|March 31, 2022
Cistrome and transcriptome analysis identifies unique androgen receptor (AR) and AR-V7 splice variant chromatin binding and transcriptional activitiesPaul Basil, Matthew J Robertson, William E Bingman, et al.
International Journal of Oncology|November 16, 2012
Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expressionSuqin He, Chaohua Zhang, Ayesha A Shafi, et al.
Oncotarget|September 18, 2015
Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cellsAyesha A Shafi, Vasanta Putluri, James M Arnold, et al.
Oncogene|November 13, 2021
Mutant p53 elicits context-dependent pro-tumorigenic phenotypesJennifer J McCann, Irina A Vasilevskaya, Christopher McNair, et al.
Pageof 3